DGNMF (Diagnamed Holdings) Stock Based Compensation: $0.15 Mil (TTM As of Mar. 2026)


What is Diagnamed Holdings Stock Based Compensation?

Diagnamed Holdings DGNMF +17.08% Stock Based Compensation is $0.15 Mil as of Mar. 2026. The stock has 1 warning sign investors should review.

Diagnamed Holdings's Stock Based Compensation for the three months ended in Mar. 2026 was $0.01 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $0.15 Mil.

Diagnamed Holdings Stock Based Compensation Related Terms

Diagnamed Holdings Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Diagnamed Holdings's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnamed Holdings Stock Based Compensation Chart

Diagnamed Holdings Annual Data
Trend Sep21 Sep22 Sep23 Sep24 Sep25
Stock Based Compensation
0.00 0.10 0.01 0.00 0.21

Diagnamed Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.02 0.12 0.01 0.01

Diagnamed Holdings Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.15 Mil.

What does a Stock Based Compensation of $0.15 Mil mean?
Diagnamed Holdings (DGNMF) has a Stock Based Compensation of $0.15 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Diagnamed Holdings and its competitors.
Is Diagnamed Holdings' Stock Based Compensation too high?
Diagnamed Holdings' current Stock Based Compensation is $0.15 Mil.
How does Diagnamed Holdings' Stock Based Compensation compare to VEEV and BTSG?
Diagnamed Holdings' Stock Based Compensation of $0.15 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Diagnamed Holdings and its competitors. Diagnamed Holdings's current Stock Based Compensation is $0.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnamed Holdings stock overvalued right now?
Diagnamed Holdings (DGNMF) has a current Stock Based Compensation of $0.15 Mil. The current Stock Based Compensation is $0.15 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Diagnamed Holdings (DGNMF), the current Stock Based Compensation is $0.15 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diagnamed Holdings Business Description

Other Exchanges DMED:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.